Daniel E. Austin and Christopher C. Mulligan discuss the latest developments in portable mass spectrometers

Mary Jo Lamberti, PhD, discusses how AI is set to change the way data is handled and used in the pharmaceutical industry

Eric Denoyer, PhD, and Joe Hedrick discuss the latest developments in GC in this Q&A

Dr. Ronald J. Kendall is head of the Wildlife Toxicology Laboratory and professor of Environmental Toxicology in the Department of Environmental Toxicology at Texas Tech University

Khalid Shah, MS, PhD, is the director of the Center for Stem Cell Therapeutics and Imaging at Harvard Medical School and the Center of Excellence in Biomedicine at Brigham and Women’s Hospital (BWH).

Dr. Christopher Brown is a co-founder, VP, and CTO of 908 Devices Inc. (Boston, MA).

Carl Wittwer, PhD, talks to contributing editor Tanuja Koppal, PhD, about polymerase chain reaction (PCR)

How to overcome common challenges of validating methods and avoid delays 

Associate editor Lauren Everett speaks with Dr. Mehdi Yazdi of SEQENS North America on the process of method validation in the pharma industry

Timothy Garrett, PhD, talks about the recent developments in mass spectrometry-based imaging and its growing applications, especially on the clinical side.

Andrea Ong is the lab manager of the Industrial Pharmacy Laboratory (IPhL) at the University
of the Sciences in Philadelphia, Pennsylvania.

How recent advances in technology have helped bring cell therapies to the forefront